farnesyl monophosphate   Click here for help

GtoPdb Ligand ID: 2911

Abbreviated name: FMP
PDB Ligand
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 76.57
Molecular weight 302.16
XLogP 3.12
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(=CCCC(=CCOP(=O)(O)O)C)CCC=C(C)C
Isomeric SMILES C/C(=C/CC/C(=C\COP(=O)(O)O)/C)/CCC=C(C)C
InChI InChI=1S/C15H27O4P/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-19-20(16,17)18/h7,9,11H,5-6,8,10,12H2,1-4H3,(H2,16,17,18)/b14-9-,15-11-
InChI Key ALEWCKXBHSDCCT-FBXUGWQNSA-N
References
1. Liliom K, Tsukahara T, Tsukahara R, Zelman-Femiak M, Swiezewska E, Tigyi G. (2006)
Farnesyl phosphates are endogenous ligands of lysophosphatidic acid receptors: inhibition of LPA GPCR and activation of PPARs.
Biochim Biophys Acta, 1761 (12): 1506-14. [PMID:17092771]
2. Williams JR, Khandoga AL, Goyal P, Fells JI, Perygin DH, Siess W, Parrill AL, Tigyi G, Fujiwara Y. (2009)
Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation.
J Biol Chem, 284 (25): 17304-19. [PMID:19366702]